Saud Alsifri

546 total citations
26 papers, 398 citations indexed

About

Saud Alsifri is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Saud Alsifri has authored 26 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Saud Alsifri's work include Diabetes Treatment and Management (11 papers), Diabetes Management and Research (10 papers) and Diabetes and associated disorders (6 papers). Saud Alsifri is often cited by papers focused on Diabetes Treatment and Management (11 papers), Diabetes Management and Research (10 papers) and Diabetes and associated disorders (6 papers). Saud Alsifri collaborates with scholars based in Saudi Arabia, United Kingdom and Egypt. Saud Alsifri's co-authors include Bernhard Ludvik, Maja Cigrovski Berković, Ambady Ramachandran, G. R. Galstyan, Ronnie Aronson, Kamlesh Khunti, Helge Gydesen, Erik Moberg, Ulrik Pedersen‐Bjergaard and Nebojša Lalić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Atherosclerosis and Diabetes Obesity and Metabolism.

In The Last Decade

Saud Alsifri

22 papers receiving 387 citations

Peers

Saud Alsifri
Simon Ashwell United Kingdom
Ellie S. Strock United States
Bahareh Rasouli Sweden
Sigrun Merger Germany
Joseph Henske United States
Sherry Martin United States
Lise Brøndsted Denmark
Helen Bui Canada
F. Storms United Kingdom
Annie Nikolajsen Denmark
Simon Ashwell United Kingdom
Saud Alsifri
Citations per year, relative to Saud Alsifri Saud Alsifri (= 1×) peers Simon Ashwell

Countries citing papers authored by Saud Alsifri

Since Specialization
Citations

This map shows the geographic impact of Saud Alsifri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saud Alsifri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saud Alsifri more than expected).

Fields of papers citing papers by Saud Alsifri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saud Alsifri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saud Alsifri. The network helps show where Saud Alsifri may publish in the future.

Co-authorship network of co-authors of Saud Alsifri

This figure shows the co-authorship network connecting the top 25 collaborators of Saud Alsifri. A scholar is included among the top collaborators of Saud Alsifri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saud Alsifri. Saud Alsifri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alsagheir, Afaf, Ahmed El-Laboudi, Fatheya Alawadi, et al.. (2025). Expert Opinion Statement on Continuous Glucose Monitoring in Type 2 Diabetes in the Arab Gulf Region. Journal of Diabetes Science and Technology. 581002956–581002956.
2.
Al‐Jedai, Ahmed, et al.. (2025). Saudi Consensus Report on Chronic Kidney Disease Management: Integrating the Latest Evidence and Clinical Practice Guidelines. International Journal of Clinical Medicine. 16(1). 54–88.
3.
4.
Abaalkhail, Faisal, Faisal M. Sanai, Khalid Alswat, et al.. (2025). Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards. Saudi Journal of Gastroenterology. 32(2). 104–120. 1 indexed citations
5.
Hassanein, Mohamed, et al.. (2024). Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study. Diabetes Research and Clinical Practice. 209. 111567–111567. 2 indexed citations
6.
Alzahrani, Saad, et al.. (2024). Oral semaglutide effectiveness and safety in real world practice; The REVOLUTION study. SHILAP Revista de lepidopterología. 14. 100209–100209. 2 indexed citations
7.
AlHabeeb, Waleed, Abdelfatah Elasfar, Abdulhalim Jamal Kinsara, et al.. (2024). A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus. Journal of the Saudi Heart Association. 36(4). 385–407. 1 indexed citations
8.
AlHabeeb, Waleed, Abdulhalim Jamal Kinsara, Adel Tash, et al.. (2024). A Saudi Heart Association Position Statement on Obesity and Cardiovascular Disease. Journal of the Saudi Heart Association. 36(3). 263–300. 1 indexed citations
9.
Alsifri, Saud, et al.. (2023). Safety of Empagliflozin in Patients with Type 2 Diabetes Mellitus in Saudi Arabia: A Post-Authorisation Safety Study. International Journal of Clinical Medicine. 14(3). 129–147.
10.
11.
Alharbi, Bandar, Turki Alharbi, Samia Bokhari, et al.. (2023). Saudi Consensus for Oral Semaglutide, the Recent Innovation in GLP-1 RAs Era; Consensus Report. Journal of Diabetes Mellitus. 13(2). 222–238. 3 indexed citations
12.
13.
Aleissa, Mohammed S., et al.. (2022). Perceptions and Preferences Toward GLP-1 Receptor Agonists in Type 2 Diabetes Management in Saudi Arabia: A Cross-sectional, Two-arm Study. Acta Scientific Medical Sciences. 41–46. 3 indexed citations
14.
Alsifri, Saud, et al.. (2022). Saudi Consensus for GLP-1 RAs Switching Guidance: Consensus Report. International Journal of Clinical Medicine. 13(1). 22–35. 1 indexed citations
15.
Al‐Saleh, Yousef, Shaun Sabico, Amin Jayyousi, et al.. (2021). Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas. Diabetes Therapy. 12(8). 2115–2132. 9 indexed citations
16.
Khunti, Kamlesh, Saud Alsifri, Ronnie Aronson, et al.. (2017). Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Research and Clinical Practice. 130. 121–129. 53 indexed citations
17.
Al‐Rasadi, Khalid, Wael Almahmeed, Khalid F. AlHabib, et al.. (2016). Dyslipidaemia in the Middle East: Current status and a call for action. Atherosclerosis. 252. 182–187. 37 indexed citations
18.
Mbanya, Jean Claude, et al.. (2015). Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach. Diabetes Research and Clinical Practice. 109(2). 226–232. 27 indexed citations
19.
Khunti, Kamlesh, Saud Alsifri, Ronnie Aronson, et al.. (2014). PO118 SELF-REPORTED HYPOGLYCEMIA: A GLOBAL STUDY OF 24 COUNTRIES WITH 27,585 INSULIN-TREATED PATIENTS WITH DIABETES: THE HAT STUDY. Diabetes Research and Clinical Practice. 106. S105–S106. 8 indexed citations
20.
Alsifri, Saud, et al.. (2004). Idiopathic Neurohypophysial Diabetes Insipidus: Reversibility of Structural and Functional Renal Abnormalities after Treatment. Endocrine Practice. 10(6). 487–491. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Ashwell Breakdown of academic impact, for papers by Ellie S. Strock Breakdown of academic impact, for papers by Bahareh Rasouli Breakdown of academic impact, for papers by Sigrun Merger Breakdown of academic impact, for papers by Joseph Henske Breakdown of academic impact, for papers by Sherry Martin Breakdown of academic impact, for papers by Lise Brøndsted Breakdown of academic impact, for papers by Helen Bui Breakdown of academic impact, for papers by F. Storms Breakdown of academic impact, for papers by Annie Nikolajsen
Rankless by CCL
2026